eFFECTOR Therapeutics, Inc. - *W EXP 12/31/202 (EFTRW)

Historical Portfolio Holders from Q3 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / *W EXP 12/31/202
Shares, excl. options Q2 2024
2.79M
Holdings value Q2 2024
$3.41K
Value change Q2 2024
-$3.13K
Grand Portfolio weight change Q2 2024
0%
Number of holders
10
Number of buys Q2 2024
3
Number of sells Q2 2024
-5
Average buys Q2 2024 %
0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 2.79M $3.41K -$3.13K $0.00 12
2024 Q1 2.6M $355K -$21K $0.14 15
2023 Q4 2.06M $239K -$150 $0.15 9
2023 Q3 1.22M $92.4K -$2.3K $0.08 10
2023 Q2 2.77M $454K -$8.45K $0.17 13
2023 Q1 2.13M $228K +$2.31K $0.13 10
2022 Q4 574K $94K -$4.4K $0.16 9
2022 Q3 2.89M $534K -$132K $0.20 13
2022 Q2 3.35M $797K -$30.9K $0.23 17
2022 Q1 3.43M $1.31M -$3.08K $0.41 20
2021 Q4 3.33M $2.94M -$459K $0.88 20
2021 Q3 3.5M $5.66M +$5.66M $1.60 25